File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer

TitleUse of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer
Authors
Ngan, HYSWong, LCChan, SYWMa, HK
Issue Date1989
PublisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno
Citation
Gynecologic Oncology, 1989, v. 35 n. 2, p. 259-262 How to Cite?
DOI: http://dx.doi.org/10.1016/0090-8258(89)90056-5
AbstractSerum squamous cell carcinoma antigen levels of 15 patients with recurrent or progressive squamous cell carcinoma of the cervix on chemotherapy treatment were assayed. In 13 of these 15 patients (87.7%), clinical response was positive correlated with change in serum SCC level. A stationary or rising serum SCC level indicated that the disease is probably stationary or progressive and chemotherapy should be stopped or changed.
Persistent Identifierhttp://hdl.handle.net/10722/173150
ISSN
0090-8258
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.627
ISI Accession Number ID
WOS:A1989AW22600029

 

DC FieldValueLanguage
dc.contributor.authorNgan, HYSen_US
dc.contributor.authorWong, LCen_US
dc.contributor.authorChan, SYWen_US
dc.contributor.authorMa, HKen_US
dc.date.accessioned2012-10-30T06:28:11Z-
dc.date.available2012-10-30T06:28:11Z-
dc.date.issued1989en_US
dc.identifier.citationGynecologic Oncology, 1989, v. 35 n. 2, p. 259-262en_US
dc.identifier.issn0090-8258en_US
dc.identifier.urihttp://hdl.handle.net/10722/173150-
dc.description.abstractSerum squamous cell carcinoma antigen levels of 15 patients with recurrent or progressive squamous cell carcinoma of the cervix on chemotherapy treatment were assayed. In 13 of these 15 patients (87.7%), clinical response was positive correlated with change in serum SCC level. A stationary or rising serum SCC level indicated that the disease is probably stationary or progressive and chemotherapy should be stopped or changed.en_US
dc.languageengen_US
dc.publisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygynoen_US
dc.relation.ispartofGynecologic Oncologyen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAntigens, Neoplasmen_US
dc.subject.meshAntineoplastic Agents - Therapeutic Useen_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Therapeutic Useen_US
dc.subject.meshCisplatin - Administration & Dosageen_US
dc.subject.meshFemaleen_US
dc.subject.meshFluorouracil - Administration & Dosageen_US
dc.subject.meshHumansen_US
dc.subject.meshLymphatic Metastasisen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshSerpinsen_US
dc.subject.meshUterine Cervical Neoplasms - Blood - Drug Therapy - Immunologyen_US
dc.titleUse of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical canceren_US
dc.typeArticleen_US
dc.identifier.emailNgan, HYS:hysngan@hkucc.hku.hken_US
dc.identifier.authorityNgan, HYS=rp00346en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/0090-8258(89)90056-5-
dc.identifier.pmid2807021-
dc.identifier.scopuseid_2-s2.0-0024455634en_US
dc.identifier.volume35en_US
dc.identifier.issue2en_US
dc.identifier.spage259en_US
dc.identifier.epage262en_US
dc.identifier.isiWOS:A1989AW22600029-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridNgan, HYS=34571944100en_US
dc.identifier.scopusauthoridWong, LC=7402092003en_US
dc.identifier.scopusauthoridChan, SYW=7404255960en_US
dc.identifier.scopusauthoridMa, HK=7403095603en_US
dc.identifier.issnl0090-8258-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats